Compare Trump Media and Technology Group Corp (DJT) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trump Media and Technology Group Corp vs Davita Inc — how do they compare? Trump Media and Technology Group Corp trades at $8.16 (market cap $2.28B), while Davita Inc trades at $179.24 (market cap $11.29B). The key difference: Davita Inc is far larger — about 5× Trump Media and Technology Group Corp's market cap, and Davita Inc is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and Davita Inc for 113 Days on average.
| DJT | DVA | |
|---|---|---|
Market Cap | $2.28B | $11.29B |
Volume | 3,148,379 | 582,204 |
Sector | Media | Health |
52-Week High | $17.07 | $240.96 |
52-Week Low | $7.06 | $103.87 |
Typical Hold Time | 17 Days | 113 Days |
Enterprise Value | $2.35B | $24.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DJT trades at $8.29, up 0.85% on the day, but technical indicators signal a bearish trend with 17 sell signals versus 7 buy signals. The company reported a net loss of $712.06 million on revenue of $3.68 million in 2025, with a negative net income margin of -28,860.41%. Recent news highlights a proposed merger with TAE Technologies, filed with the SEC on September 30, 2026, which could pivot the company toward fusion energy development.
The outlook remains highly speculative. The merger with TAE offers a potential long-term growth avenue in advanced technology, but severe financial losses, negative profitability ratios, and significant cash burn pose substantial risks. Investor sentiment is mixed, weighed down by the company's weak fundamentals against transformative merger prospects.
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trump Media and Technology Group Corp
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
